Bob Martin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bob Martin

Quick Facts

Property Description
Active Ingredient(s) Fenbendazol, Praziquantel, Permethrin, Pyrethrin I, Nitenpyram, etc.
Form Tablets, Spot-on Solutions, Cutaneous Sprays, Collars
Pharmacological Class Broad-spectrum Antiparasitic Agent
General Purpose Comprehensive control of internal and external parasites
Origin Synthetic Compounds and Natural Derivatives

What Type of Medicine is Bob Martin and What is its Primary Purpose?

The Bob Martin product line is a collective entity classified as a veterinary medicinal product, which operates as a broad-spectrum antiparasitic agent for use exclusively in companion animals. Its primary purpose is the comprehensive control and management of parasitic infestations, addressing both internal and external parasitic burdens simultaneously. This strategy of combining multiple active agents in antiparasitics is a recognized approach for managing complex infestations.

The entity is designed to manage the frequent co-occurrence of various parasites, including endoparasites like roundworms and tapeworms, alongside ectoparasites such as fleas and ticks, offering a practical option for routine, year-round parasite prevention.

Composition: A Combination of Anthelmintics and Insecticides

The identity of the Bob Martin line is rooted in its multimodal combination product status, defined by the inclusion of active ingredients from distinct pharmacological classes to ensure wide-ranging efficacy. The formulation integrates various Anthelmintics—specifically compounds like Fenbendazol and Praziquantel—for the elimination of internal worms, alongside Insecticides and Acaricides, such as the synthetic Permethrin and the natural derivative Pyrethrin I, for external pest control.

Praziquantel functions as an anthelmintic effective against cestodes (tapeworms) in veterinary medicine and is a key component for clearing internal parasite infections. These active substances are dispensed through diverse dosage forms, including oral tablets, spot-on solutions, and cutaneous spray solutions, a versatility that differentiates it from single-form competitive products.

How Does its Multimodal Action Achieve Comprehensive Parasite Control?

The effectiveness of this entity stems from its multimodal activity, a general principle where the different chemical components target multiple, distinct biological pathways within the parasites. This combination ensures that parasites cannot evade treatment by having immunity to a single agent; for example, the neurotoxic actions of the pyrethroids effectively paralyze and eliminate external pests, while the anthelmintics disrupt the cellular integrity of internal worms.

Pyrethroids, like Permethrin, work by causing rapid neurological disruption in insects. This mechanism functions by overloading the pest's nervous system. The overall benefit of this approach is achieving holistic parasite elimination and management through complementary physiological actions.

What side effects are possible with Bob Martin?

Possible Side Effects and Safety Information

The safety profile for the broad-spectrum antiparasitic products containing agents such as Fenbendazol, Praziquantel, Permethrin, and Pyrethrin I is structured by both the classification of adverse reactions and essential species-specific constraints documented in regulatory sources.


Adverse Reactions by System-Organ Class

Adverse reactions listed in official regulatory documents are typically categorized by the body system affected. These include:

  • Gastrointestinal Disorders: Uncommon or isolated incidents of vomiting, diarrhea, poor appetite (anorexia), and excessive salivation have been documented following the administration of the anthelmintic components.
  • Nervous System Disorders: Reactions range from muscle tremors, twitching, and incoordination to severe neurological signs and seizures, predominantly associated with pyrethroid exposure in susceptible species.
  • Skin and Subcutaneous Tissue Disorders: Localized reactions at the spot-on application site, such as temporary irritation, redness, or hair loss, are reported.

Serious Adverse Reactions and Safety Constraints

The most critical safety constraint documented in official labeling is the extreme sensitivity of felines (cats) to pyrethroids (Permethrin and Pyrethrin I). Cats lack the metabolic mechanism necessary to properly break down these compounds, and exposure to concentrated, dog-specific pyrethroid products can result in life-threatening neurological toxicosis, including status epilepticus, collapse, and fatality.

Furthermore, official safety information establishes population-specific restrictions. Certain formulations are not recommended for use in very young animals, such as puppies and kittens under specific age or weight limits, or in animals that are pregnant, lactating, or severely debilitated. Regulatory warnings emphasize that adverse events may be associated with using anthelmintic components like Fenbendazol for durations longer than specified on the label.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents describe specific manifestations and required emergency actions associated with an overdose of the active ingredients in Bob Martin products.

Documented Overdose Manifestations Overdose exposure is formally documented to present with signs primarily affecting the central nervous system and neuromuscular control. These presentations include physical tremors, muscle fasciculations, hyperexcitability, and ataxia (incoordination). Gastrointestinal effects such as vomiting and excessive salivation (ptyalism) are also cited in official reports.

Severe Outcomes and Emergency Response Overdose exposure may progress to severe, life-threatening outcomes, including seizures, cardiorespiratory arrest, and death. Specific cardiac events, such as arrhythmias, are also cited in regulatory information related to one of the components. Due to the high risk, regulatory guidelines mandate that the user seek immediate medical advice for human exposure or call the veterinary office immediately for a suspected animal overdose. Hospitalization may be required for severe neurological or cardiopulmonary compromise. Management is primarily based on supportive care and the use of specific procedural steps, such as decontamination by washing.

Critical Population Risk A critical, population-specific overdose consideration is the severe toxicity in cats. Regulatory agencies note that felines are highly susceptible to potentially fatal neurotoxicity from the pyrethroid components (Permethrin/Pyrethrin) due to known metabolic limitations.

Therapeutic Uses of Bob Martin

Quick Facts: Main Therapeutic Domains

  • Ectoparasite Management: Kills adult fleas and may repel ticks, lice, and mites.
  • Gastrointestinal Parasite Control: Treats certain internal worms in canines and felines.
  • Nutritional Supplementation: Used to support overall vitality, immune system maintenance, and healthy coat/skin condition.

Bob Martin products are utilized in veterinary supportive care for the management of various conditions in domestic animals, primarily dogs and cats.

The range of treatments addresses the necessity for ectoparasite management, which includes addressing infestations caused by adult fleas. Certain formulations contain ingredients intended to deliver immediate action against these external pests upon detection, providing temporary relief for the affected animal. This approach to control is often recommended as part of a comprehensive strategy that also includes environmental intervention to achieve successful eradication. Specialized preparations may also offer the use of repellents intended to prevent the attachment of ticks, lice, or mites.

In addition to external parasites, other products are formulated for the control of gastrointestinal parasites, such as various types of internal worms in animals. Proper application of these anti-parasitic agents assists in maintaining animal health and preventing adverse outcomes associated with parasitic infection.

Furthermore, the brand provides nutritional supplementation products. These are typically administered as a dietary complement to help maintain overall general wellbeing and support the animal's natural immune system response. Specific supplements contain vitamins and minerals intended to support metabolic functions and contribute to the maintenance of healthy bones, joints, and a normal coat condition.


Eligibility and Restrictions for Use

The eligibility for use of Bob Martin veterinary products is strictly defined by species, age, weight, and health status, as documented in official regulatory materials from the Veterinary Medicines Directorate (VMD) and similar bodies.

Eligibility Constraints (Based on Regulatory Labeling)

Classification Eligible Population Non-Eligible Population (Contraindicated)
Target Species Dogs, Cats, and Ferrets (product-specific) Species not listed (e.g., Rabbits are strictly contraindicated)
Age/Weight Animals over a defined minimum age (e.g., puppies/kittens over 2 or 8 weeks old) and a specific minimum weight (e.g., 2 kg for dogs, 1 kg for cats). Puppies or kittens below the documented age and/or minimum body weight.
Health Status Generally healthy animals. Sick or convalescent animals (e.g., with systemic diseases or fever), or those with wounds or damaged skin at the application site.
Hypersensitivity Animals with no known sensitivities. Animals with known hypersensitivity to the active ingredient (e.g., Fipronil) or any of the product's excipients.
Physiological Status Use in pregnant and nursing dogs may be allowed after a professional benefit/risk assessment. Use is generally not recommended in pregnant or nursing animals without specific veterinary guidance.

Regulatory documents explicitly prohibit use in non-target species such as rabbits, as this may result in severe adverse reactions, including death. The product is also contraindicated for all animals with a confirmed allergy to its components. Eligibility is always subject to the minimum age and weight stated on the product's specific label.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for the active ingredients in Bob Martin products outlines specific constraints and prohibitions related to co-administration and exposure. These statements are grounded strictly in government-approved labeling from authorities such as the EMA and FDA, detailing pharmacokinetic and exposure-related risks.

Interaction Classification Relevant Substance or Category Official Restriction/Condition
Contraindicated Combination Felines (Cats) with Permethrin-containing formulations Formally prohibited due to severe, species-specific metabolic toxicity.
Contraindicated Combination Strong CYP 3A Inducers (e.g., Rifampin) with Praziquantel Co-administration is contraindicated as effective plasma levels are unlikely to be achieved.
Avoidance Recommended Moderate CYP 3A Inducers (e.g., Efavirenz) with Praziquantel Concomitant use should be avoided due to risk of clinically significant plasma concentration decrease.
Clearance/Excretion Alteration Methotrexate with Fenbendazole Fenbendazole has been documented to decrease the excretion rate of Methotrexate, potentially raising its serum levels.

Mandatory Timing Restriction: The official product labeling for Permethrin-containing spot-on solutions specifies that children must not handle the treated animal for a period of at least four hours following product application.

Population-Specific Caution: For the active ingredient Praziquantel, regulatory documents indicate that patients with moderate to severe hepatic impairment (Child-Pugh Class B or C) require monitoring due to reduced drug metabolism, which can lead to higher plasma concentrations. Additionally, safety in pregnant or lactating animals is not established for certain formulations, necessitating a cautious benefit-risk assessment.

Mechanism of Action

Targeting Arthropod Nerves and Internal Parasite Metabolism

The mechanism relies on multimodal pharmacodynamic actions against external and internal parasites. The ectoparasite component (Pyrethrin I, Permethrin, Nitenpyram) delivers a dual neurotoxic insult. Pyrethroids bind to and hold open arthropod Voltage-Gated Na^+ Channels, causing persistent nerve firing, while Nitenpyram activates Nicotinic Acetylcholine Receptors (nAChR). This overloads the insect's nervous system, resulting in uncontrollable muscle spasms and sustained paralysis.

For internal parasites, complementary anthelmintic mechanisms are used. Fenbendazol interferes with the parasite's beta-tubulin, inhibiting microtubule formation and causing energy depletion. Simultaneously, Praziquantel modulates Ca^2+ channels, causing a rapid influx of calcium ions. This results in severe, spastic paralysis and structural damage that renders the internal parasite unable to maintain normal physiological function. This overall strategy incorporates multiple, distinct physiological targets across parasite groups.

Dosage and Administration Information

Official Administration Guidelines and Regulatory Status

This section outlines the essential instructions for administration as formally established by governmental drug regulatory authorities.

There are no official regulatory documents for a human medicine named "Bob Martin." Consequently, there is no state-verified, labeled information detailing its route of administration, specific dosing rules, preparation requirements, or age-group administration rules.

In the absence of a registered human drug label, the standard administrative procedures—which detail the precise way a medicine must be used—cannot be provided. These procedures typically define the required elements of use, including:

Administration Scope Regulatory Status
Route of Administration Information is not available from official government regulatory sources.
Dosing Schedule Information is not available from official government regulatory sources.
Age-Group Rules Information is not available from official government regulatory sources.

Official prescribing information for human medicines establishes a required sequence for administration, timing, and preparation steps. For "Bob Martin," this regulatory basis is missing. Using medicines with a defined regulatory status ensures the availability of validated use instructions and safety profiles.

If the product is intended for veterinary use, its instructions are governed by separate, non-human health agencies, which are outside the scope of this human drug information guide.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Bob Martin

The evidence base for the active components in the Bob Martin product line consists of study data regarding antiparasitic agents. This body of evidence includes trials specifically requested by governmental regulatory bodies to assess a product's measurable effects against specific target parasites, as well as broader peer-reviewed research on the classes of agents used, such as anthelmintics (internal worm treatments) and pyrethroids (external pest treatments).

What is the Overall Study Landscape for these Antiparasitic Agents?

The foundation of the evidence relies on controlled efficacy trials and field studies, which are the main types of research used in the veterinary context to examine parasite burden. These trials compare the medicine against an untreated control group to understand patterns observed in the studies, and to examine the consistency of findings across different animal populations. Research has explored different formulations—such as oral tablets and topical spot-on solutions—to see how symptoms evolved in the observed populations, and this evidence contributes to the broader evidence landscape of parasite management.

Evidence for Gastrointestinal Parasite (Internal Worm) Control

Research focused on the anthelmintic ingredients, like Fenbendazole and Praziquantel, was conducted in controlled settings and field environments using animals naturally or experimentally infected with common intestinal worms, such as roundworms and tapeworms.

  • What was studied: Research trials were used to examine short-term symptom changes. The primary outcomes measured included parasite egg counts, evaluating the reduction or elimination of parasite eggs, which was observed by performing Fecal Egg Count Reduction Tests (FECRT).
  • What remains uncertain: Long-term effects are not fully established; specifically, long-term information regarding the durability of parasite control beyond 90 days remains limited across all available studies. Data for certain groups, particularly concerning the impact of emerging antiparasitic resistance in local regions, remain insufficient.

Evidence for Ectoparasite (Fleas and Ticks) Management

Evidence for external parasite findings, including components like Permethrin and Pyrethrin I, is based on controlled efficacy studies applied in research contexts involving fluctuating symptoms caused by external infestation.

  • What was studied: Research examined the speed of ectoparasite mortality (the immediate or "knock-down" effect) and the duration of residual activity over defined time intervals.
  • What remains uncertain: Follow-up durations were limited to the intended dosing interval, meaning long-term effects beyond the period of residual activity are not fully established. Furthermore, scientific literature describes a growing prevalence of resistance to pyrethroids in certain flea populations, meaning findings may vary by geographic location.

Key Studies & References

  1. Efficacy of Fenbendazole and Praziquantel-Emodepside against Infection of Oxyurid Eggs in Green Iguana (Iguana iguana) - Fecal Egg Count Reduction Test (FECRT) used
  2. Efficacy of a New Fenbendazole Treatment Protocol against Capillaria spp. in Northern White-Breasted Hedgehog (Erinaceus roumanicus) - FECRT study
  3. VICH Task Force for Efficacy Studies for Combination Products - Regulatory guidance on combination product efficacy

Frequently Asked Questions (FAQ)

Common questions about Bob Martin (FAQ)

Q: Does Bob Martin require a prescription in most countries?

Bob Martin products are classified as veterinary medicines. According to official regulatory frameworks, such as those governed by the UK's Veterinary Medicines Directorate (VMD), many formulations are approved for general sale directly to the public. This suggests that many Bob Martin products are available over the counter and may not require a specific veterinary prescription.

Q: Does Bob Martin cause drowsiness?

Official regulatory safety documents for the active ingredients list potential nervous system disorders. These reactions may include signs such as depression, decreased activity, or increased sensitivity to stimulation in the animal. Drowsiness itself is not explicitly listed as a reported adverse reaction.

Q: Are the side effects of Bob Martin usually temporary?

Studies on the active ingredients indicate that many adverse reactions are transient, meaning they are short-lived. The adverse reactions documented for some formulations, such as those caused by Nitenpyram, are described as transient. Recovery has been observed to occur rapidly due to the compound's quick elimination from the animal’s system.

Q: How long does Bob Martin stay in your system after you stop taking it?

The time the components remain in the body varies by active ingredient and species. Official pharmacokinetic information for Nitenpyram indicates that its elimination half-life is documented as approximately 4 hours in dogs and 8 hours in cats. The vast majority of this component is eliminated in the urine within one to two days.

Q: Is Bob Martin safe to take if I also take a common antibiotic?

Bob Martin is a veterinary medicine, not a human drug. Official documentation for the active ingredients notes potential interactions with certain medicines that may alter how quickly the body processes the antiparasitic agent. The potential risk depends on the specific class of antibiotic being used in the animal. It is important to review all concurrent medications with the prescribing professional.

Q: Are there any common foods or drinks that should be avoided while using Bob Martin?

Regulatory guidance generally does not require the avoidance of common foods or drinks when using the main antiparasitic formulations. For the oral tablet containing Nitenpyram, official product information states that it can be administered with or without food, as feeding does not affect its absorption in dogs.

Q: Is Bob Martin a narcotic or controlled substance?

No. The active ingredients found in Bob Martin products, such as the anthelmintics Fenbendazol and Praziquantel, are not classified as narcotics or controlled substances. This determination is based on the classification systems used by major drug regulatory bodies.

Q: Does Bob Martin have a risk of dependence?

Based on the regulatory classification of the active ingredients, there is no documented risk of physical or psychological dependence associated with the product. The components are not controlled substances, which eliminates the primary source of dependence risk found in certain other medications.

Q: Is Bob Martin known to interact with herbal supplements?

Official regulatory safety documents typically do not contain specific information on interactions between the active ingredients and most herbal or complementary supplements. This indicates that these combinations have not been systematically studied and are not documented in the official product information.

Q: Does the time of day matter when taking Bob Martin?

The time of day does not impact the pharmacological effect of the oral tablet formulations. However, for certain spot-on solutions, official guidance suggests applying the product in the early evening. This is a safety recommendation to ensure the application site is completely dry before children handle the treated animal.

Q: What happens if a dose of Bob Martin is missed?

General regulatory guidance for anthelmintic ingredients suggests that if an oral dose is missed, it should be administered when remembered. If it is near the time for the next scheduled dose, regulatory information states that the missed dose is typically skipped. Official guidance advises against doubling the dose and recommends continuing with the regular schedule.

Q: Do studies suggest Bob Martin's effects are consistent across different age groups?

Research into the active ingredient Permethrin indicates that drug exposure levels can vary depending on the animal’s age. For instance, younger animals may experience higher plasma concentrations than adults. Regulatory guidance already accounts for this by establishing specific age and weight restrictions for use in certain animals.

Q: What is the purpose of the filler ingredients in Bob Martin tablets?

Official regulatory documents list inactive ingredients, also known as excipients. These components are added for functional reasons, such as acting as carriers or antioxidants, to ensure the product’s stability. They also aid in manufacturing and often help with palatability for the animal.

Q: Are there different strengths of Bob Martin available?

Yes. The Bob Martin product line includes different formulations and package sizes designed to accommodate the wide range of animal weights. These products effectively provide different strengths to match the weight-based dose requirements for small, medium, and large animals.

Q: Why is it important to check the expiration date on Bob Martin?

The expiration date provides a regulatory assurance that the product will maintain its documented potency and efficacy until that date. This assurance is valid only if the product has been stored correctly according to official instructions. Using an expired product may result in the active ingredients being less effective at controlling parasites.

Q: Are there reports of Bob Martin causing unusual mood changes?

Regulatory documents on possible side effects list potential nervous system disorders that can be observed in the animal. These reported reactions include signs that could be perceived as behavioral or mood alterations, such as depression or increased sensitivity to stimulation.

Q: What does the patient information leaflet say about stopping Bob Martin?

Patient information for the anthelmintic ingredients generally instructs that the medicine should be used for the full recommended duration. Official guidance advises against stopping the medication early, as this may lead to treatment failure and require re-treatment of the parasitic infection.

How should Bob Martin be stored and disposed of?

How to Store and Dispose of Bob Martin?

Official regulatory documents define strict requirements for storing and disposing of Bob Martin veterinary medicinal products to maintain their 2-year shelf-life and ensure safety.

Mandatory Storage Conditions

Storage must adhere to specific environmental constraints, including: Do not store above 25 C and keep the product in a dry place. The medicine must be kept in the original packaging, ensuring the product stays within its outer carton until use. All products must be stored out of the sight and reach of children and away from food and animal feed.

Disposal Instructions

Unused or expired product and waste materials must be disposed of in accordance with local requirements. Due to potential environmental risks from the active ingredients, it is explicitly mandated: Do not contaminate ponds, waterways or ditches with the product or empty container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bob Martin found in:

A-Z Index: